FindTrial
Sign In

A prospective, multi-centre, randomised trial comparing low-dose aspirin with low-dose aspirin plus low-intensity oral anticoagulation in the primary prevention of thrombosis in patients positive for antiphospholipid antibodies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81818945
Enrollment
Unknown
Registered
2002-02-04
Start date
2000-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of thrombosis Circulatory System Thrombosis

Interventions

Patients will be randomised to either low dose (75 mg) aspirin or low-dose aspirin and low international normalised ratio (INR) warfarin

Sponsors

Arthritis Research Campaign (ARC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients positive for antiphospholipid antibodies

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026